Skip to content

Free cash flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Stryker logo
StrykerSYK
$415M+227%
CONMED logo
CONMEDCNMD
$10.58M-72.0%
Enovis logo
EnovisENOV
-$28.85M+35.7%
OrthoPediatrics logo
OrthoPediatricsKIDS
-$5.05M+39.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%

Valuation

See full
Market cap$258.19M-26.6%
Enterprise value$320.25M-22.6%
P/S1.3×-0.4×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s free cash flow?
Treace Medical Concepts, Inc. (TMCI) reported free cash flow of $4.18M in Q1 2026.
How has Treace Medical Concepts, Inc.'s free cash flow changed year-over-year?
Treace Medical Concepts, Inc.'s free cash flow increased by 537.9% year-over-year, from $655K to $4.18M.
What is the long-term trend for Treace Medical Concepts, Inc.'s free cash flow?
Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s free cash flow has grown at a 10.3% compound annual growth rate (CAGR), from -$19.9M to -$29.49M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.